TRH mimetics: differentiation of antiamnesic potency from antidepressant effect

Bioorganic & Medicinal Chemistry
A A MazurovT A Voronina

Abstract

For the purpose of rational modification of the TRH molecule, we were pursuing an approach that consists of two steps: (1) 'obligatory' replacement of histidine with glutamine in TRH and (2) the application of conformational constraints for putative bioactive conformation I stabilized by an intramolecular hydrogen bond between C-terminal carboxamide proton and alpha-carbonyl of histidyl (glutaminyl), and conformation II formed by an intramolecular hydrogen bond between alpha-carbonyl of pyroglutamyl and prolinamide proton. Significant antiamnesic potency was discovered in the passive avoidance test (ECS and Scopolamine induced amnesia) for conformation II mimic (8S,10aS)-8-carbamoyl-1,2,3,6,7,8,9,10a- octahydro-5H,10H-pyrrolo[1,2-a][1,4]diazocin-5,10-dione (2) at doses of 0.1 and 1.0 mg/kg. EEG analysis indicates a mild activating effect of compound 2 on EEG, which is similar to that of piracetam and differs from hard amphetamine activation. Conformation I mimic 3-(2-carbamoylethyl)-2,3,6,7,8,8a-hexahydro-1H,4H-pyrrolo[1,2-a] pyrazin-1,4-dione (1) exhibited an antidepressant effect at a dose of 1 mg/kg. The transition from two putative quasi-cyclic bioactive conformations of TRH and its obligatory similar analogue [Gln2]-TRH to...Continue Reading

References

Feb 15, 1978·European Journal of Pharmacology·R D PorsoltM Jalfre
Jul 15, 1992·Biological Psychiatry·G K TsuboyamaR C Mohs
Jan 1, 1992·Pharmacology, Biochemistry, and Behavior·S A StwertkaA G Verderese
May 3, 1990·European Journal of Pharmacology·S VonhofV M Labroo
Jan 1, 1989·Progress in Neuro-psychopharmacology & Biological Psychiatry·U Schindler
Jan 1, 1986·Annual Review of Pharmacology and Toxicology·A HoritaH Lai
Nov 1, 1987·Clinical Science·E C Griffiths
Jan 1, 1988·Psychopharmacology·R VerloesE Wülfert
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M Zasloff
Jan 1, 1985·Progress in Neuro-psychopharmacology & Biological Psychiatry·G G Yarbrough, N Pomara
Nov 11, 1972·Lancet·A J PrangeG R Breese
Mar 16, 1974·Life Sciences·G R BreeseM A Lipton
Oct 1, 1974·The American Journal of Medicine·R E Peterson, R Guillemin
Nov 6, 1969·Biochemical and Biophysical Research Communications·J BolerA V Schally
Aug 1, 1966·Journal of Molecular Biology·F H Crick
Jan 1, 1981·Progress in Neurobiology·J L MartinezJ L McGaugh
Jan 1, 1983·Neuropsychobiology·A GlattH Demieville
Dec 1, 1982·Journal of Pharmacological Methods·S BanfiL Dorigotti
Sep 1, 1995·Journal of Neurochemistry·R O'Leary, B O'Connor
Sep 1, 1993·Molecular and Cellular Endocrinology·S M DuthieK A Eidne
Jul 1, 1993·International Journal of Peptide and Protein Research·A A MazurovY E Shapiro

❮ Previous
Next ❯

Citations

May 7, 2005·Neuroscience and Biobehavioral Reviews·Ewa Malatynska, Richard J Knapp
Nov 17, 2020·Frontiers in Molecular Biosciences·Irina Y FilippovaElena N Elpidina
Jun 30, 2010·Journal of Natural Products·Xiuli WuJiangong Shi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.